about
Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical reviewCirculating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.Epithelial Barrier Function in Gut-Bone Signaling.Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Utility of Biomarkers in IBD.
@en
type
label
Clinical Utility of Biomarkers in IBD.
@en
prefLabel
Clinical Utility of Biomarkers in IBD.
@en
P2860
P1476
Clinical Utility of Biomarkers in IBD.
@en
P2093
Luc Biedermann
P2860
P2888
P356
10.1007/S11894-015-0449-X
P577
2015-07-01T00:00:00Z
P6179
1033734238